Tucson Nonprofit Seeks to Get Cures to Patients Faster A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and develo
New Corporate Members and Leaders for C-Path’s Predictive Safety Testing Consortium Announced The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Con
C-Path Receives $675,000.00 Award for FDA Collaboration The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of wh
Valley Fever Cure a Step Closer The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent year
C-Path Announces the Appointment of Jeffery Cossman, M.D., as Chief Scientific Officer The Critical Path Institute (C-Path), today announced the appointment of Jeffrey Cossman, M.D., an internationally recognized expe
FDA Release: The Predictive Safety Testing Consortium The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Sa
C-Path Forms Drug Testing Pact The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companie
Drug Research Institute Sdds Liason From UA The retired head of research at the University of Arizona has joined the Tucson-based Critical Path Institute, a UA- and FDA-affil
C-Path to Spur Medical Innovation We all remember the Vioxx scare and authorities say it could happen again. However, the FDA is stepping up its efforts to improve